Ultrasound contrast imaging for prostate cancer before surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial uses a special ultrasound with a contrast agent to take detailed images of the prostate before surgery. It may help doctors see the cancer more clearly and plan the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are a man diagnosed with prostate cancer.
- Your cancer has been confirmed by a biopsy.
- You are scheduled to have surgery to remove your prostate.
- You do not have severe high blood pressure in the lungs or other conditions that make contrast agents unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special PET scan (PSMA-PET) plus MRI is better than MRI alone at finding the full extent of high-risk prostate cancer before surgery. It aims to improve surgical planning by checking scan results against the removed prostate tissue.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This trial compares two ways to treat early prostate cancer: a single small surgery through the bladder versus high-intensity focused ultrasound (HIFU). It aims to see which approach works better while keeping side effects and recovery acceptable.
This trial tests a new type of ultrasound, called micro-ultrasound, to see if it can better find significant prostate cancer in men who are on active surveillance. If you qualify, this could help your doctor decide if your cancer is truly low-risk.
This trial tests whether using a PSMA-PET scan before prostatectomy can guide surgery in a way that helps preserve sexual function. It may be most helpful if you have certain kinds of prostate cancer and want to keep erections after surgery.
This trial tests whether adding a targeted biopsy to a standard sextant biopsy improves the detection of prostate cancer. It is for men aged 45 to 85 who have a suspicious spot on an MRI of their prostate and have not had a biopsy before.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.